Presenter Information

Emma SimmonsFollow

Major

Chemistry

Anticipated Graduation Year

2022

Access Type

Restricted Access

Abstract

The discovery of antibiotics has been crucial in human health and increasing the average life expectancy. As pathogenic bacteria have evolved and developed multidrug resistance, this has restricted the effectiveness of our current antibiotic arsenal, producing an urgent need for the discovery of new antibiotics. The enzyme Na+-NQR has been identified as a novel antibiotic target exclusively found in pathogens and is crucial for the survival of pathogenic bacteria. Lead compounds were discovered by screening ubiquinone-like compounds against the enzyme to identify those with inhibitory activity, including endochin. Compounds have been designed and synthesized to produce more potent and selective inhibitors of Na+-NQR.

Community Partners

Illinois Institute of Technology

Faculty Mentors & Instructors

Dr. Daniel Becker, Professor of chemistry and faculty mentor, Department of Chemistry; Zachary Liveris, graduate student mentor, Department of Chemistry

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Share

COinS
 

Design and Synthesis of Sodium-dependent NADH:Ubiquinone Oxidoreductase (Na+-NQR) Inhibitors as Novel Antibiotics

The discovery of antibiotics has been crucial in human health and increasing the average life expectancy. As pathogenic bacteria have evolved and developed multidrug resistance, this has restricted the effectiveness of our current antibiotic arsenal, producing an urgent need for the discovery of new antibiotics. The enzyme Na+-NQR has been identified as a novel antibiotic target exclusively found in pathogens and is crucial for the survival of pathogenic bacteria. Lead compounds were discovered by screening ubiquinone-like compounds against the enzyme to identify those with inhibitory activity, including endochin. Compounds have been designed and synthesized to produce more potent and selective inhibitors of Na+-NQR.